Patients with Relapsing MS May Find Help from Plegridy Injections
The FDA has recently announced the approval of a new drug used to treat relapsing multiple sclerosis. Manufacturer Biogen Idec Inc. announced their peg interferon beta-1a injection, known as Plegridy, received approval as a treatment option for relapsing forms of MS. By attaching a polyethylene glycol molecule to the interferon beta-1a, it extends the medication’s […]
